Search results
Results From The WOW.Com Content Network
Researcher working with the Ebola virus while wearing a BSL-4 positive pressure suit. There is a cure for the Ebola virus disease that is currently approved for market the US government has inventory in the Strategic National Stockpile. [1] For past and current Ebola epidemics, treatment has been primarily supportive in nature. [2]
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. [1] Symptoms typically start anywhere between two days and three weeks after infection. [3] The first symptoms are usually fever, sore throat, muscle pain, and headaches. [1]
From March 2015 through November 2015, 72 individuals infected with the Ebola virus were enrolled in the trial; investigators stopped enrolling new subjects in January 2016, having failed to reach its enrollment goal of 200 due to the waning of the Ebola outbreak. As a result, although a 40% lower risk of death was calculated for those who ...
Tanzania’s president has confirmed an outbreak of the deadly Marburg virus disease (MVD), a highly infectious virus like Ebola that can be fatal in up to 88 per cent of cases without treatment. ...
The New York Times published an interesting piece on Ebola facts and how many have been treated for the deadly virus outside of Africa, including who has recovered, who are still in treatment and ...
Ebola is a terrifying virus which, if left untreated, causes bleeding inside the body and through the eyes, nose, mouth and rectum. Case fatality rates have varied from 25% to 90% in past ...
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication used for the treatment of Zaire ebolavirus (Ebolavirus) infection. [2] [3]The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.
Another company, Emergent BioSolutions, was a contestant for manufacturing new doses of ZMapp, [citation needed] a drug for Ebola virus disease treatment originally developed by Mapp Biopharmaceutical. [83] Supplies of ZMapp ran out in August 2014. [84]